GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian Response

Study Overview
=================
Brief Summary
-----------------
During the last decades, owing to the growing tendency of women to delay childbearing plans because of career and personal priorities, fertility specialists today are seeing more and more women with poor ovarian reserve and with poor ovarian response Controlled ovarian hyperstimulation (COH) is considered a important factor in the success of in vitro fertilization-embryo transfer (IVF-ET), enabling the recruitment of multiple oocytes and, thereby, resulting in more than one embryo. However, owing to the extreme variability in ovarian response to COH, in a subgroup of patients with poor ovarian response, this method may yield a very small number of follicles After succeeding in maximal recruitment of the follicles, the triggering of ovulation is extremely important in order to achieve, as many as, mature oocytes. Several studies have reported retrieval of more mature oocytes after GnRH agonist triggering compared to the number of oocytes retrieved after hCG. Among the possible advantages of GnRH agonist for final oocyte maturation is the simultaneous induction of an FSH surge. The role of the natural mid-cycle FSH surge is not fully clear. FSH was reported to induce LH receptor formation in luteinizing granulosa cells, and to promote oocyte nuclear maturation and cumulus expansion . Another method described to trigger ovulation is the Dual triggering- GnRH agonist 40 h prior to ovum pickup and hCG added 6 h after the first trigger. The dual triggering was described as the treatment in cases with recurrent empty follicles. The aim of the present study is to evaluate three different methods of ovulation triggering in women with poor ovarian response

Detailed Description
-----------------
Inclusion criteria: Women with low ovarian response according to the Bologna criteria, undergoing IVF treatments for this cause. Exclusion criteria: Women with good ovarian response. Women with low ovarian response who are carriers of fragile X

Official Title
-----------------
GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian

Conditions
-----------------
Women With Poor Ovarian Response

Intervention / Treatment
-----------------
* Drug: Ovitrel
* Drug: Decapeptyl


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Women with low ovarian response according to the Bologna criteria, undergoing IVF treatments for this cause. Exclusion Criteria: Women with good ovarian response. Women with low ovarian response who are carriers of fragile X

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: GnRH agonist<br> | Drug: Decapeptyl<br>* Triggering with GnRH agonist<br>|
| Active Comparator: hCG<br> | Drug: Ovitrel<br>* Triggering of ovulation with Ovitrel<br>|
| Active Comparator: dual triggering: GnRH agonist and hCG<br> | Drug: Ovitrel<br>* Triggering of ovulation with Ovitrel<br>Drug: Decapeptyl<br>* Triggering with GnRH agonist<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The main outcome is the number of mature oocytes |  | up to 12 months | 
| number of embryos appropriate for transfer |  | up to 12 month | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| pregnancy rate |  | up to 12 months |